---
$id: https://graph.org.ai/products/commodity/51434805
$type: Product
source: UNSPSC
code: "51434805"
title: "Dagapamil"
class: "51434800"
classTitle: "Antihypertensive drugs, synthesized"
family: "51430000"
familyTitle: "Antihypertensive drugs"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Dagapamil

**UNSPSC Code**: 51434805
**Class**: [Antihypertensive drugs, synthesized](Antihypertensive drugs, synthesized.mdx)
**Family**: [Antihypertensive drugs](../Antihypertensive drugs.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a calcium channel blocker with the molecular formula C36H56N2O4, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 64O87U613H, chemically known as 2-(3-((m-methoxyphenethyl)methylamino)propyl)-2-(3,4,5-trimethoxyphenyl)tetradecanenitrile. but generally known as dagapamil, which bears US NIH Compound Identifier 205957. European Medicines Agency schedules Dagapamil in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06888MIG. The term DAGAPAMIL is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 39, No. 5, 1985, List 25). DAGAPAMIL is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule dagapamil under HS 29269095 and SITC 51484. As of Q4 2014, DAGAPAMIL remains the US FDA Preferred Term for this commodity. Dagapamil bears US NLM identifiers UMLS ID C2825727 and NCI Concept Code C81681. SMILES: O(c1cc(C(CCCCCCCCCCCC)(CCCN(CCc2cc(OC)ccc2)C)C#N)cc(OC)c1OC)C.

